The United Nations is set to review the legal status of nicotine, sparked by a submission from the Pacific island nation of Palau. The Guardian's editorial argues that while an outright global ban would be excessive, there is no justification for the easy availability of nicotine products, especially given their rapid proliferation in a regulatory grey area that has specifically targeted children.
Health Case Against Cigarettes Remains Ironclad
As Gro Harlem Brundtland, former head of the World Health Organization, stated in 2000, “a cigarette is the only consumer product which when used as directed kills its consumer.” Smoking remains the leading cause of preventable death worldwide. Many countries, including the UK, have implemented strong restrictions on cigarettes and other tobacco products. However, over the past two decades, tobacco-free nicotine products such as vapes and nicotine pouches—using synthetic versions of the addictive ingredient—have surged in popularity.
Palau Pushes for UN Vote on Nicotine Ban
Palau has tasked the WHO Expert Committee on Drug Dependence with reviewing nicotine, leading to a potential UN vote, likely in 2028, on banning it worldwide. The case hinges partly on whether addiction and dependence themselves—absent other major health consequences—constitute harm. The editorial notes that smoking taught us it is often better to stamp out highly addictive habits before consequences become obvious later, but there are also reasons for caution.
Benefits for Smokers Switching to Vapes
Nicotine products offer some benefits. There are still 1.2 billion smokers globally, and a recent Cochrane review found that people who switch to vaping are twice as likely to quit smoking. Palau’s submission includes data linking nicotine to cardiovascular disease and other conditions, but a recent Royal College of Physicians report in the UK concluded that “current evidence suggests nicotine itself confers little risk to health.”
Regulatory Gaps and Targeting Children
Regulators cannot rely solely on current science. Palau’s submission reflects frustration that the nicotine market emerged rapidly in a regulatory grey area, deliberately targeting children. A WHO report found that children are on average nine times more likely than adults to vape. Some e-cigarettes contain harmful ingredients like heavy metals, and nicotine is proven to harm adolescent brain development. The UK did not introduce vape-specific legislation until 2016; prior law covered only tobacco. It is understandable that countries do not want to continue this regulatory Whac-A-Mole, evaluating each new addictive product only after it gains public traction. Banning nicotine would address the problem at its source.
Middle Ground: Restrictions Without Prohibition
The editorial advocates for a middle ground. The UK smoking ban coming into effect next year will also restrict e-cigarette displays and advertising, and leaves room to limit child-friendly flavours. Ministers should go further. The Canadian province of Quebec has fully banned flavoured vapes and limits nicotine pouch sales to pharmacies. Such restrictions should apply to all forms of nicotine to prevent novel products from evading existing regulations, while still allowing suffering smokers and consenting adults limited access.
Conclusion: Caution on Synthetic Nicotine
Synthetic nicotine, free from tobacco carcinogens, presents a fascinating case—offering addiction without other obvious harm. However, there is no clear benefit to widespread availability, the science on pure nicotine use remains limited, and downstream products like vapes are not benign. Addictive substances are inherently difficult for individuals to control, which is why countries may need to manage them.
